ISDA

Deposition Date 2019-11-21

Release Date 2020-10-28

Last Version Date 2024-05-01

Entry Detail

PDB ID:

6THW

Keywords:

SIGNALING PROTEIN

Title:

IRAK4 in complex with inhibitor

Biological Source:

Source Organism:

Homo sapiens (Taxon ID: 9606)

Host Organism:

Spodoptera frugiperda

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

2.44 Å

R-Value Free:

0.27

R-Value Work:

0.24

R-Value Observed:

0.24

Space Group:

I 2 2 2

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Molecule:Interleukin-1 receptor-associated kinase 4
Gene (Uniprot):IRAK4
Chain IDs:A, B
Chain Length:308
Number of Molecules:2
Biological Source:Homo sapiens

UniProt ID:Q9NWZ3 Pfam ID:PF07714

Ligand Molecules

NBK

Primary Citation

Improving metabolic stability and removing aldehyde oxidase liability in a 5-azaquinazoline series of IRAK4 inhibitors.

Degorce, S.L, Aagaard, A, Anjum, R, Cumming, I.A, Diene, C.R, Fallan, C, Johnson, T, Leuchowius, K.J, Orton, A.L, Pearson, S, Robb, G.R, Rosen, A, Scarfe, G.B, Scott, J.S, Smith, J.M, Steward, O.R, Terstiege, I, Tucker, M.J, Turner, P, Wilkinson, S.D, Wrigley, G.L, Xue, Y.Show

Bioorg.Med.Chem. 28 115815 115815 (2020)

PMID: 33091850 DOI: 10.1016/j.bmc.2020.115815

Abstact

In this article, we report our efforts towards improving in vitro human clearance in a series of 5-azaquinazolines through a series of C4 truncations and C2 expansions. Extensive DMPK studies enabled us to tackle high Aldehyde Oxidase (AO) metabolism and unexpected discrepancies in human hepatocyte and liver microsomal intrinsic clearance. Our efforts culminated with the discovery of 5-azaquinazoline 35, which also displayed exquisite selectivity for IRAK4, and showed synergistic in vitro activity against MyD88/CD79 double mutant ABC-DLBCL in combination with the covalent BTK inhibitor acalabrutinib.

Legend

Protein

Chemical

Disease

Primary Citation of related structures